Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-11
2006-04-11
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07026332
ABSTRACT:
Methods of treating obsessive-compulsive disorder comprising administering2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone are disclosed.
REFERENCES:
patent: 4960779 (1990-10-01), Bourzat et al.
patent: 5494915 (1996-02-01), Barreau et al.
patent: 5498716 (1996-03-01), David-Comte et al.
patent: 2003/0092719 (2003-05-01), Day et al.
patent: 2 305 859 (1997-04-01), None
patent: WO 93/01187 (1993-01-01), None
patent: WO 93/01189 (1993-01-01), None
patent: WO9301198 (1993-01-01), None
patent: WO 93/05041 (1993-03-01), None
patent: WO 93/11125 (1993-06-01), None
patent: WO 94/05663 (1994-03-01), None
patent: WO 01/08670 (2001-02-01), None
patent: WO0108670 (2001-02-01), None
Clary Cathryn M.
Donevan Sean
Eisman Perry S.
Kavoussi Richard
Ma Lyou-Fu
Indevus Pharmaceuticals, Inc.
Katten Muchin & Rosenman LLP
Spivack Phyllis G.
Villacorta Gilberto M.
LandOfFree
Methods of treating obsessive-compulsive disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating obsessive-compulsive disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating obsessive-compulsive disorder will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3594600